May 16, 2017 7:40am
… Still get no respect
Quarterly results are important, but cell therapy stocks in particular have more than a lot to prove each three-month period.
… Let’s play sell once more so we can buy again
Mixed open expected
Companies in my headlights: eight (8), 2 BUY and 6 SELLs
Critical information ahead of “our” universe’s open! I provide intelligence and analysis for short and near-term investment.
Members only. Please login.